These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31217025)

  • 21. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.
    Ghosh R; Lewis D
    Expert Opin Drug Saf; 2015; 14(12):1845-53. PubMed ID: 26436834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The WHO World Alliance for Patient Safety: a new challenge or an old one neglected?
    Edwards IR
    Drug Saf; 2005; 28(5):379-86. PubMed ID: 15853440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safe Use of Recent New Drugs-Current Status and Challenges].
    Ohashi Y
    Yakugaku Zasshi; 2018; 138(2):177-183. PubMed ID: 29386431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal Management in Pharmacovigilance: A Review of Activities and Case Studies.
    Beninger P
    Clin Ther; 2020 Jun; 42(6):1110-1129. PubMed ID: 32487428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role and Responsibilities of Various Stakeholders in Pharmacovigilance (PV).
    Phougat P; Beniwal M; Kapoor G; Aggarwal N; Kumari A; Sharma R; Chopra H; Sharma R; Kamal MA
    Curr Drug Saf; 2024 Feb; ():. PubMed ID: 38318830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Enigma of Pharmacovigilance of Patient Support Programs: A Survey of Marketing Authorization Holders in Europe.
    Portnoff JM; Lewis DJ
    Ther Innov Regul Sci; 2017 Jul; 51(4):486-493. PubMed ID: 30227052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Internet and drug safety: what are the implications for pharmacovigilance?
    Cobert B; Silvey J
    Drug Saf; 1999 Feb; 20(2):95-107. PubMed ID: 10082068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety Alerts: An Observational Study in Portugal.
    Soares S; Roque F; Teixeira Rodrigues A; Figueiras A; Herdeiro MT
    Clin Ther; 2015 Sep; 37(9):2122-8. PubMed ID: 26256430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The condition of health services in the Gaza Strip.
    Med War; 1990; 6(2):140-51. PubMed ID: 2215363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities.
    Lewis DJ; McCallum JF
    Ther Innov Regul Sci; 2020 Jul; 54(4):888-899. PubMed ID: 32557311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacovigilance Agreements: Negotiating Safety Data Exchange Timelines: To Agree to Disagree? That is the Question.
    Manko Singer W; Pileggi EM; Gibble Y; Lewis DJ
    Ther Innov Regul Sci; 2023 Sep; 57(5):1050-1061. PubMed ID: 37341970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
    Amarasinghe A; Black S; Bonhoeffer J; Carvalho SM; Dodoo A; Eskola J; Larson H; Shin S; Olsson S; Balakrishnan MR; Bellah A; Lambach P; Maure C; Wood D; Zuber P; Akanmori B; Bravo P; Pombo M; Langar H; Pfeifer D; Guichard S; Diorditsa S; Hossain MS; Sato Y
    Vaccine; 2013 Apr; 31 Suppl 2():B108-14. PubMed ID: 23598471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.
    Smith MY; Benattia I
    Drug Saf; 2016 Sep; 39(9):779-85. PubMed ID: 27098248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining national burn care policies--is the Israeli burn care alignment based on national data?
    Haik J; Weissman O; Givon A; Liran A; Tessone A; Stavrou D; Orenstein A; Peleg K;
    J Burn Care Res; 2012; 33(4):510-7. PubMed ID: 22337322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.